Clene Inc (CLNN)
0.3772
-0.01
(-2.18%)
USD |
NASDAQ |
May 17, 16:00
0.3772
0.00 (0.00%)
After-Hours: 20:00
Clene Price to Book Value: 11.14 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 11.14 |
| May 16, 2024 | 11.61 |
| May 15, 2024 | 11.52 |
| May 14, 2024 | 11.57 |
| May 13, 2024 | 11.77 |
| May 10, 2024 | 11.64 |
| May 09, 2024 | 11.66 |
| May 08, 2024 | 11.74 |
| May 07, 2024 | 11.79 |
| May 06, 2024 | 12.76 |
| May 03, 2024 | 13.10 |
| May 02, 2024 | 13.15 |
| May 01, 2024 | 13.16 |
| April 30, 2024 | 13.01 |
| April 29, 2024 | 10.59 |
| April 26, 2024 | 10.24 |
| April 25, 2024 | 10.44 |
| April 24, 2024 | 10.15 |
| April 23, 2024 | 10.09 |
| April 22, 2024 | 10.03 |
| April 19, 2024 | 10.52 |
| April 18, 2024 | 9.937 |
| April 17, 2024 | 10.23 |
| April 16, 2024 | 9.337 |
| April 15, 2024 | 9.982 |
| Date | Value |
|---|---|
| April 12, 2024 | 10.83 |
| April 11, 2024 | 11.47 |
| April 10, 2024 | 11.87 |
| April 09, 2024 | 11.81 |
| April 08, 2024 | 12.02 |
| April 05, 2024 | 12.46 |
| April 04, 2024 | 12.73 |
| April 03, 2024 | 12.26 |
| April 02, 2024 | 11.93 |
| April 01, 2024 | 12.65 |
| March 31, 2024 | |
| March 28, 2024 | 4.080 |
| March 27, 2024 | 4.076 |
| March 26, 2024 | 4.068 |
| March 25, 2024 | 4.124 |
| March 22, 2024 | 4.259 |
| March 21, 2024 | 4.076 |
| March 20, 2024 | 3.837 |
| March 19, 2024 | 3.847 |
| March 18, 2024 | 3.902 |
| March 15, 2024 | 3.837 |
| March 14, 2024 | 4.028 |
| March 13, 2024 | 4.216 |
| March 12, 2024 | 4.259 |
| March 11, 2024 | 4.268 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.560
Minimum
Dec 27 2023
2845.39
Maximum
Feb 16 2021
242.51
Average
15.15
Median
Mar 24 2022
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.808 |
| AIM ImmunoTech Inc | 2.107 |
| IGC Pharma Inc | 3.942 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 2.806 |
Price to Book Value Related Metrics
| PS Ratio | 70.35 |
| PEG Ratio | -0.0448 |
| Price | 0.3772 |
| Earnings Yield | -124.3% |
| Market Cap | 47.52M |
| PEGY Ratio | -0.0448 |